340 studies found for:    Emphysema
Show Display Options
RSS Create an RSS feed from your search for:
Emphysema
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Assessment of Emphysema Using 1.5T MRI With UTE Pulse Sequences
Condition: Emphysema
Intervention: Other: MR and CT measurements of emphysema quantification
2 Completed Tiotropium Induced Bronchodilation in Lung CT Scored Emphysema
Conditions: COPD;   Emphysema
Intervention: Drug: tiotropium
3 Recruiting Rehabilitation in Chronic Obstructive Pulmonary Disease (COPD) Patients With Emphysema
Conditions: Chronic Obstructive Pulmonary Disease;   Emphysema
Intervention:
4 Completed Single-Breath Measurement Underestimates Ventilatory Volume According to Emphysema Severity
Condition: Emphysema
Intervention:
5 Unknown  Endoscopic Lung Volume Reduction in Patients With Advanced Emphysema Due to alpha1 Antitrypsin Deficiency
Condition: Hereditary Emphysema (Alpha 1-antitrypsin Deficiency)
Intervention: Device: Implantation of intrabronchial valves (IBV) (Spiration IBV)
6 Recruiting Sequential Segmental Treatment of Emphysema With Upper Lobe Predominance (STEP-UP) Study
Condition: Emphysema
Interventions: Device: InterVapor® treatment plus Optimal Medical Therapy;   Other: Optimal Medical Therapy
7 Completed Study on Phenotypic Characterization of Combined Pulmonary Fibrosis and Emphysema
Conditions: Pulmonary Fibrosis;   Emphysema
Intervention:
8 Completed Use of Endobronchial Valves in Non-Upper Lobe Heterogeneous Emphysema
Condition: Heterogeneous Emphysema
Intervention: Device: Intra-bronchial valve (Spiration IBV)
9 Terminated Study of the AeriSeal System for HyPerInflation Reduction in Emphysema (ASPIRE)
Condition: Pulmonary Emphysema
Interventions: Device: Treatment plus Optimal Medical Therapy;   Other: Optimal Medical Therapy
10 Active, not recruiting Extension Study of Zemaira® i.v. Administration in Subjects With Emphysema Due to alpha1-proteinase Inhibitor Deficiency.
Conditions: Emphysema;   Alpha 1-proteinase Inhibitor Deficiency
Intervention: Biological: Alpha1- proteinase inhibitor [human]
11 Recruiting Prostaglandin Inhibition for Emphysema
Condition: Emphysema
Interventions: Drug: 600 mg ibuprofen three times daily for 48 weeks;   Other: Placebo three times daily
12 Recruiting Long Term Follow up Investigation of Endobronchial Valves in Emphysema
Condition: Pulmonary Emphysema
Intervention: Device: Zephyr Endobronchial Valve (EBV)
13 Completed Zemaira in Subjects With Emphysema Due to Alpha1-Proteinase Inhibitor (API) Deficiency
Conditions: Alpha1-proteinase Inhibitor Deficiency;   Emphysema
Interventions: Biological: Alpha1-proteinase inhibitor;   Other: Placebo
14 Unknown  AeriSeal System in Patients With Advanced Upper Lobe Predominant Emphysema and Collateral Ventilation
Conditions: Pulmonary Emphysema;   COPD;   Lung Diseases
Intervention: Device: AeriSeal System
15 Completed
Has Results
Alpha-1-Antitrypsin (AAT) To Treat Emphysema In AAT-Deficient Patients (EXACTLE)
Condition: Alpha 1-Antitrypsin Deficiency
Interventions: Drug: Alpha1-Proteinase Inhibitor (Human);   Drug: Albumin (Human) 20%, United States Pharmacopeia (USP)
16 Completed Exhale (R) Stent for Emphysema
Condition: Emphysema
Intervention: Device: Exhale Drug-Eluting Stent
17 Completed Pneumocystis in Pathogenesis of HIV-associated Emphysema
Conditions: HIV Infections;   Pneumocystis Pneumonia;   Emphysema;   Chronic Obstructive Pulmonary Disease;   Asthma
Intervention:
18 Withdrawn Study of the AeriSeal System Treatment in Patients With Advanced Non-Upper Lobe Predominant Heterogeneous Emphysema
Conditions: Emphysema;   Chronic Obstructive Pulmonary Disease (COPD)
Intervention: Device: AeriSeal Emphysematous Lung Sealant Syst
19 Terminated Israeli 10 mL Bronchoscopic Lung Volume Reduction (BLVR) Phase 1/2 Emphysema Study - Initial Formulation
Condition: Pulmonary Emphysema
Intervention: Biological: BLVR Hydrogel
20 Terminated Netherlands 10 mL Bronchoscopic Lung Volume Reduction (BLVR) Phase 1/2 Emphysema Study - Initial Formulation
Condition: Pulmonary Emphysema
Intervention: Biological: BLVR Hydrogel

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years